Usana Health Sciences Newsroom

D.A. Davidson Maintains Usana Health Sciences(USNA.US) With Hold Rating, Cuts Target Price to $35

Moomoo NewsOct 23 09:34 ET

Usana Health Sciences Analyst Ratings

BenzingaOct 23 06:42 ET

Usana Health Sciences Analyst Ratings

BenzingaJul 25 07:04 ET

USANA Health Sciences Has Expectation for a Continued Challenging Operating Environment Across Many Markets

Dow JonesJul 23 16:20 ET

USANA Health Sciences: 2Q Operating Results Were Below Our Expectations >USNA

Dow JonesJul 23 16:20 ET

Usana Health Sciences Analyst Ratings

BenzingaMay 7 09:08 ET

Usana Health Sciences Analyst Ratings

BenzingaFeb 22 11:54 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $53

BenzingaOct 25, 2023 12:16 ET

Usana Health Sciences Analyst Ratings

BenzingaOct 25, 2023 12:15 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $56

BenzingaApr 26, 2023 10:12 ET

Usana Health Sciences Analyst Ratings

Benzinga Analyst RatingsFeb 13, 2023 10:03 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $52.5

Benzinga Real-time NewsFeb 13, 2023 10:03 ET

DA Davidson Adjusts USANA Health Sciences' Price Target to $49 From $57, Keeps Neutral Rating

MT NewswiresOct 27, 2022 10:57 ET

Usana Health Sciences Analyst Ratings

Benzinga Analyst RatingsOct 27, 2022 04:53 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $49

Benzinga Real-time NewsOct 27, 2022 04:51 ET

Usana Health Sciences analyst ratings

Benzinga Analyst RatingsJul 28, 2022 06:24 ET

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $57

Benzinga Real-time NewsJul 28, 2022 06:24 ET

USANA Health Sciences Is Maintained at Neutral by DA Davidson

Dow JonesJul 12, 2022 05:18 ET

USANA Health Sciences Price Target Cut to $58.00/Share From $76.00 by DA Davidson

Dow JonesJul 12, 2022 05:18 ET

Usana Health Sciences analyst ratings

Benzinga Analyst RatingsJul 12, 2022 05:08 ET